28 maj 2019
Ascelia is developing a new contrast agent to improve cancer diagnotics of patients with impaired kidney function. A pivotal trial is set to start in 2019 and the prospects for success are promising, in our view.
Read the full report (Swedish) here.
Vi använder oss av cookies för att garantera dig den bästa upplevelsen av vår hemsida. Mer info
Office Management & Accounting
Telefon: +44 20 8017 6020
@
Associate
Telefon: +45 2621 0543
Managing Partner
Telefon: +45 4199 8252
Telefon: +46 70 496 18 15
Partner
Telefon: +49 30 809 3347 33
Office Management & HR
Telefon: +49 89 255 495 310
Telefon: +49 40 300 836 10
Telefon: +44 20 80176020
Senior Equity Analyst
Telefon: +46 70 434 90 03
Head of Equity Sales
Telefon: +46 73 382 10 82
Telefon: +46 707 40 68 58
Telefon: +49 89 255 49 53-11
Telefon: +49 40 300 836-19
PR, Marketing & Business Development Manager
Telefon: +49 40 300 836 18
Director
Telefon: +46 73 850 35 59
Office Management
Telefon: +49 30 809 33 47-10
Telefon: +45 4199 8251
Telefon: +49 40 300 836-26
Telefon: +49 40 300 836-28
Telefon: +49 40 300 836-15
Telefon: +49 30 809 33 47-12
Vice President
Telefon: +46 70 246 99 88
Telefon: +44 77 1347-8286
IT&Telecom Expert
Telefon: +49 89 255 49 53-18
Head of Operations
Telefon: +49 30 809 33 47 16
Telefon: +49 89 255 49 53-15
Telefon: +49 40 300 836-11
Head of Equity Research
Telefon: +46 76 235 03 20
Telefon: +49 40 300 836-20
Telefon: +49 89 255 49 53 24
Telefon: +49 30 809 33 47-13
Telefon: +49 40 300 836-24
Telefon: +45 2634 9031
Telefon: +49 89 255 49 53-17
Telefon: +49 30 809 33 47-25
Telefon: +49 40 300 836-21
Telefon: +49 40 300 836-14
Associate Equity Analyst
Telefon: +46 73 539 66 99
Telefon: +49 89 255 49 53-12
Telefon: +49 89 255 49 53 26
Business Development & Marketing
Telefon: +44 20 8017 6017
Telefon: +49 30 809 33 47-20
Senior Advisor Life Sciences
Telefon: +46 73 312 44 90
